These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 25950242)
1. Subjective response as a consideration in the pharmacogenetics of alcoholism treatment. Roche DJ; Ray LA Pharmacogenomics; 2015; 16(7):721-36. PubMed ID: 25950242 [TBL] [Abstract][Full Text] [Related]
2. Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone. Setiawan E; Pihl RO; Benkelfat C; Leyton M Pharmacogenomics; 2012 Jul; 13(10):1161-72. PubMed ID: 22909206 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic treatments for drug addiction: alcohol and opiates. Haile CN; Kosten TA; Kosten TR Am J Drug Alcohol Abuse; 2008; 34(4):355-81. PubMed ID: 18584566 [TBL] [Abstract][Full Text] [Related]
4. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Ray LA; Hutchison KE Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatment of alcoholism. Anton RF; Schacht JP; Book SW Handb Clin Neurol; 2014; 125():527-42. PubMed ID: 25307594 [TBL] [Abstract][Full Text] [Related]
6. Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism. Enoch MA Pharmacol Biochem Behav; 2014 Aug; 123():17-24. PubMed ID: 24220019 [TBL] [Abstract][Full Text] [Related]
7. The μ-opioid receptor and treatment response to naltrexone. Thorsell A Alcohol Alcohol; 2013; 48(4):402-8. PubMed ID: 23543091 [TBL] [Abstract][Full Text] [Related]
8. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial. Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804 [TBL] [Abstract][Full Text] [Related]
9. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH; Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034 [TBL] [Abstract][Full Text] [Related]
10. Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging. Mann K; Vollstädt-Klein S; Reinhard I; Leménager T; Fauth-Bühler M; Hermann D; Hoffmann S; Zimmermann US; Kiefer F; Heinz A; Smolka MN Alcohol Clin Exp Res; 2014 Nov; 38(11):2754-62. PubMed ID: 25421512 [TBL] [Abstract][Full Text] [Related]
11. Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. Cservenka A; Yardley MM; Ray LA Am J Addict; 2017 Aug; 26(5):516-525. PubMed ID: 28134463 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic approaches to the treatment of alcohol addiction. Heilig M; Goldman D; Berrettini W; O'Brien CP Nat Rev Neurosci; 2011 Oct; 12(11):670-84. PubMed ID: 22011682 [TBL] [Abstract][Full Text] [Related]
13. The pharmacogenetics of alcohol use disorder. Jones JD; Comer SD; Kranzler HR Alcohol Clin Exp Res; 2015 Mar; 39(3):391-402. PubMed ID: 25703505 [TBL] [Abstract][Full Text] [Related]
14. Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence. Anton RF Pharmacogenomics; 2008 Jun; 9(6):655-8. PubMed ID: 18518841 [No Abstract] [Full Text] [Related]
15. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Ray LA; Barr CS; Blendy JA; Oslin D; Goldman D; Anton RF Alcohol Clin Exp Res; 2012 Mar; 36(3):385-94. PubMed ID: 21895723 [TBL] [Abstract][Full Text] [Related]
16. Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators. Ooteman W; Naassila M; Koeter MW; Verheul R; Schippers GM; Houchi H; Daoust M; van den Brink W Addict Biol; 2009 Jul; 14(3):328-37. PubMed ID: 19523047 [TBL] [Abstract][Full Text] [Related]
17. Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Krishnan-Sarin S; Krystal JH; Shi J; Pittman B; O'Malley SS Biol Psychiatry; 2007 Sep; 62(6):694-7. PubMed ID: 17336941 [TBL] [Abstract][Full Text] [Related]
18. Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone. Oslin DW; Berrettini WH; O'Brien CP Addict Biol; 2006 Sep; 11(3-4):397-403. PubMed ID: 16961767 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of alcohol, nicotine and drug addiction treatments. Sturgess JE; George TP; Kennedy JL; Heinz A; Müller DJ Addict Biol; 2011 Jul; 16(3):357-76. PubMed ID: 21362114 [TBL] [Abstract][Full Text] [Related]
20. Subjective Response to Alcohol as a Research Domain Criterion. Ray LA; Bujarski S; Roche DJ Alcohol Clin Exp Res; 2016 Jan; 40(1):6-17. PubMed ID: 26727518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]